Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Data is the fuel that keeps Wall Street's engine turning -- and one of the most important data releases of...
Global market volatility has left investors searching for direction. Veteran investor Ramesh Damani said that while the market’s sharp swings...
Asian airline stocks plunged on Monday, part of a broader market reaction to the U.S. and Israel’s decision to strike...
The Nifty IT index remains under sustained technical pressure, with recent attempts at recovery lacking conviction and failing to alter...
The United Arab Emirates has sold itself to foreigners for years as a sunny, safe, tax-free oasis. That peaceful image was shattered...
Mumbai: A risk-off wave is set to sweep across equity markets early this week, as US-Israeli military actions against Iran...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
